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Abstract
Introduction: The aim of this study was to evaluate the functional changes of the arterial endothelium and
smooth muscle after a high-voltage electrical injury (HVEI), using flow-mediated dilation (FMD) and nitrate-
mediated dilation (NMD).
Methods: Twenty-five male patients injured in the upper extremities by current due to contact with more than
20,000 volts were enrolled in the study. FMD and NMD were measured on the brachial artery within 48 hours after
HVEI, and follow-up FMD and NMD were evaluated six weeks later. In addition, we enrolled an age, sex and body
mass index matched healthy control group consisting of 25 individuals. Including FMD and NMD, all the variables
of the control group were investigated one time and compared with the initial and six week follow-up data of the
HVEI group.
Results: A significantly lower initial FMD was seen in the HVEI group compared with the control group (2.1 ± 1.2%
versus 13.6 ± 3.4%, P < 0.01). At the six week follow-up, the FMD of the HVEI group had significantly improved
compared to the initial FMD (2.1 ± 1.2% versus 5.1 ± 2.1%, P < 0.01), but it was still lower than the FMD of the
control group (5.1 ± 2.1% versus 13.6 ± 3.4%, P < 0.01). A significantly lower NMD was seen both initially and at
the six week follow-up compared with the NMD of the control group (7.3 ± 4.7% versus 20.4 ± 4.1%, P < 0.01 and
11.4 ± 6.7% versus 20.4 ± 4.1%, P < 0.01, respectively). The FMD study of the contralateral arm which was
uninjured by HVEI was available in six patients. In those patients, the six week follow-up FMD was significantly
improved in the HVEI arm compared with the initial FMD (1.8 ± 0.6% versus 4.4 ± 1.6%, P < 0.01). However, in the
contralateral uninjured arm, there was no difference between the initial and the six week follow-up FMDs (5.5 ±
1.4% versus 6.9 ± 2.2%, P = 0.26).
Conclusions: After HVEI, the endothelial and smooth muscle functions of the brachial artery were significantly
decreased for at least six weeks. Long term cautious care might be needed for all victims of HVEI, because there is
a chance of increased risk of thrombosis or stenosis in the injured arm.
Keywords: high-voltage electrical injury, endothelium, smooth muscle, arterial function, flow-mediated dilation,
nitrate-mediated dilation
Introduction
High-voltage electrical injury (HVEI) is defined as expo-
sure to more than 1,000 volts and it causes devastating
local and systemic damage [1]. Usually, HVEI is asso-
ciated with entry and exit wounds, and assessment of
the pathway allows prediction of the organs at most risk
of damage [2]. In HVEI, nearly 90% of victims have inju-
ries in their upper extremities [3,4], with amputation
required in 24% to 49% of cases [5,6]. The extent of the
injury depends on the electrical voltage, the local tissue
resistance, the pathway of the current flow, and the
duration of the contact [7]. The severity of the damage
to the arteries is also a critical factor [8]. In a mouse
femoral artery model of extensive electrical injury, Car-
meliet et al. showed that the recovery process of the
endothelium and smooth muscle was quickly initiated
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and reached a peak two weeks after injury [9]. However,
the functional changes that occur in human arteries
after HVEI have not yet been studied. Therefore, the
purpose of the present study was to evaluate the func-
tional changes of the arterial endothelium and smooth
muscle after HVEI using flow-mediated dilation (FMD)
and nitrate-mediated dilation (NMD).
Materials and methods
Study population
Patients were eligible for enrollment in this study if they
were over 18 and under 65 years of age, injured in the
upper extremities, and had undergone HVEI of more
than 20,000 volts in an upper extremity. Patients were
excluded if they were injured more than 48 hours before
the study; had any cardiovascular disease, diabetes, renal
insufficiency, or left ventricular dysfunction (LVEF <
55%); had no HVEI in an upper extremity; had serious
external wounds or ischemic changes in the injured
upper extremity; had sepsis and systemic shock; or if
they were unable to follow the protocol. In addition, we
enrolled an age, sex, and body mass index matched
healthy control group to compare the data of the
patients with HVEI.
Measurement of the FMD and NMD
The patients in this study, whose arms had been injured
by high-voltage electrical current, were evaluated using
FMD and NMD. An experienced vascular sonographer
performed an ultrasound examination using a Vivid 7
ultrasound system (GE Vingmed Ultrasound, Horten,
Norway) with a 12 MHz linear array transducer. The
baseline study was conducted within 48 hours after
HVEI and the follow-up study was conducted six weeks
after the initial study. FMD and NMD were measured
according to the recommendations of Coretti and col-
leagues [10]. In brief, patients were told not to exercise,
not to ingest substances that might affect FMD and
NMD, such as caffeine, foods, or vasoactive medication,
and not to use tobacco for at least 12 hours before the
study. A landmark was chosen 5 cm proximal to the
antecubital crease and the brachial artery (BA) was
imaged. The baseline diameter of the BA was measured
from 2-dimensional gray scale longitudinal images. Sub-
sequently, a blood pressure cuff was inflated at the distal
forearm up to 220 mmHg for five minutes. After cuff
release, the BA diameter was measured again at 40, 60,
80, and 90 seconds. Ten minutes after taking the mea-
surements, an exogenous nitric oxide donor, sublingual
nitroglycerin (0.6 mg), was administered. Three minutes
after that, images were recorded for NMD measure-
ments. All images were recorded digitally by capturing
the BA in the longitudinal plane with an electrocardio-
gram. The BA diameter image for analysis was chosen
at the onset of the R-wave on the electrocardiogram.
Measurements were performed at seven points, and the
highest and lowest values were discarded. The mean
value from the remaining five measurements was used
for further analysis. The follow-up FMD and NMD were
measured six weeks later. Including the FMD and
NMD, all of the control group variables were investi-
gated only one time. One cardiologist (WJP), who was
blinded to the participants’ clinical data, interpreted the
ultrasound results using an off-line method.
Echocardiographic assessment
One experienced sonographer, who was blinded to the
patients’ information, performed the echocardiography.
The two-dimensional (2D) M-mode image was recorded
using an echocardiography machine (Vivid 7; GE Medi-
cal Systems, Milwaukee, USA) according to the guide-
lines of the American Society of Echocardiology [11].
The left ventricular ejection fraction was quantified by
Simpson’s rule using the 2D echocardiography images
from the apical four-chamber view [12]. Measurements
were made on-line and recorded digitally with partici-
pants’ initials and study number as their only forms of
identification. One cardiologist (MKK), blinded to the
participant’s clinical data, interpreted the echocardio-
gram using an off-line method.
Statistical analysis
Data are presented as mean ± standard deviation (SD).
Comparisons of data across the two time points (within
48 hours after injury and six weeks after injury) were
performed using Student’s 2-tailed, paired t test. Com-
parisons were made between the HVEI group and the
control group using either an independent samples t
test or a Mann Whitney U test. Differences in categori-
cal variables between the two groups were analyzed with
either the Chi-square test or Fisher’s exact test. Statisti-
cal analyses were performed using SPSS version 17.0
(SPSS Inc., Chicago, IL, USA). All probability values
were two-sided. A value of P < 0.05 indicated statistical
significance. This study was approved by the Institu-
tional Review Board of the Hallym University Medical
Center (IRB No. 2009-062) and all patients gave their
written informed consent.
Results
Between February 2010 and April 2011, 94 victims of
HVEI were assessed. Most of them were electrical engi-
neers who were injured while repairing an industrial
electrical transformer (n = 56) or power pole (n = 21).
The rest were injured while working at a drainage pump
station (n = 10), doing sign work (n = 3), or landscaping
work (n = 2), and so on. Among the screened victims,
69 patients were excluded for the following reasons:
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serious injury to both arms (n = 36), admitted more
than 48 hours after the event (n = 12), were without
electrical injury in an upper extremity (n = 7), multi-
organ failure or sepsis (n = 6), combined serious flame
burns on both arms (n = 4), diabetes (n = 2), or refused
to participate in the study (n = 2). Among the 25
enrolled HVEI patients, nine had unilateral upper extre-
mity HVEI. The mean value of the serum creatinine
kinase was 5,133 ± 7,716 IU/L and myoglobinuria was
detected in 84% (21 out of 25) of the studied patients.
During the study, two patients did not undergo the six
week follow-up FMD and NMD because arterial throm-
bosis and obstruction led to musculocutaneous flap fail-
ure and amputation of the distal injured arm in the
second and third weeks after HVEI.
Baseline patient characteristics
No significant differences were noted between the HVEI
group and the control group in terms of baseline clinical
characteristics including age, body mass index, cardio-
vascular risk factors, and medications used, except for
elevated fasting glucose and high-sensitive C-reactive
protein in the HVEI group (Table 1).
Changes in clinical parameters and arterial function
The changes in the clinical parameters and arterial func-
tions are shown in Table 2. The initial systolic and dia-
stolic blood pressure and heart rate were higher in the
HVEI group than in the control group, but no difference
was observed at the six week follow-up. The BA was sig-
nificantly enlarged during the initial study in the HVEI
group compared with the control group (4.4 ± 0.6 mm
versus 3.9 ± 0.4 mm, P < 0.01). However, no difference
was seen in the size of the BA between the HVEI group
and the control group at the six week follow-up (4.1 ±
0.5 mm versus 3.9 ± 0.4 mm, P = 0.07). During the
study period, no difference was observed in left ventri-
cular function between the HVEI group and the control
group.
Changes in FMD and NMD
The initial FMD was significantly lower in the HVEI
group than in the control group (2.1 ± 1.2% versus 13.6
± 3.4%, P < 0.01, Figure 1). At the six week follow-up,
the FMD was significantly improved in the HVEI group
compared with the initial FMD (2.1 ± 1.2% versus 5.1 ±
2.1%, P < 0.01), but it was still lower than the FMD of
the control group (5.1 ± 2.1% versus 13.6 ± 3.4%, P <
0.01). The six week follow-up NMD improved in the
HVEI group compared with the initial NMD (7.3 ± 4.7%
versus 11.4 ± 6.7%, P < 0.01, Figure 2). However, both
the initial and the six week follow-up NMDs were sig-
nificantly lower in the HVEI group than in the control
group (7.3 ± 4.7% versus 20.4 ± 4.1%, P < 0.01 and 11.4
± 6.7% versus 20.4 ± 4.1%, P < 0.01, respectively).
Among the 25 enrolled patients, nine had unilateral
upper extremity HVEI. The contralateral arm was evalu-
ated for the study in six out of those nine patients,
because three patients suffered from severe contralateral
axillary wounds as exit-point injuries, which may affect
the flow of the brachial artery and influence the FMD
results of the contralateral uninjured arm. The FMD
changes in the six patients are presented in Figure 3. At
the six week follow-up, the FMD was significantly
improved in the HVEI arm compared with the initial
FMD (1.8 ± 0.6% versus 4.4 ± 1.6%, P < 0.01). However,
in the contralateral uninjured arm, there was no differ-
ence between FMDs in the initial study and at the six
week follow-up (5.5 ± 1.4% versus 6.9 ± 2.2%, P = 0.26).
In addition, the six week follow-up FMD of the contral-
ateral injured arm was significantly lower than the
matched control (6.9 ± 2.2% versus 13.6 ± 4.4%, P <
0.01).
Discussion
The principal finding of this study was that, following
HVEI, the endothelial and smooth muscle functions of
the injured artery were significantly decreased even after
six weeks, compared to the arterial functions of the
healthy controls.
The human body is a good electrical conductor and
the systemic effects and tissue damage are directly pro-
portional to the magnitude of the current drawn by the
victim [1]. These injuries can result in life-threatening
complications, such as respiratory arrest, ventricular
fibrillation and acute renal failure [13]. Many cases of









Age (years) 48 ± 11 48 ± 11 0.94
Hypertension 6 (24%) 7 (28%) 0.75
Current smoking 14 (56%) 9 (36%) 0.26
Body mass index (Kg/m2) 23.6 ± 2.6 23.6 ± 2.0 0.99
Hemoglobin (gm/dL) 14.7 ± 1.1 14.9 ± 1.1 0.62
Glucose (mg/dL) 110 ± 18 90 ± 11 < 0.01
Total cholesterol (mg/dL) 175 ± 27 185 ± 26 0.18
Creatinine (mg/dL) 0.8 ± 0.2 0.8 ± 0.1 0.65
High-sensitive C-reactive protein
(mg/dL)
51.2 ± 43.2 0.9 ± 0.6 < 0.01
Aspirin 2 (8%) 5 (20%) 0.42
Beta-blocker 1 (4%) 2 (8%) 1.00
ACEI/ARB 2 (8%) 5 (20%) 0.42
Calcium channel blocker 6 (24%) 3 (12%) 0.46
Statin 1 (4%) 4 (16%) 0.35
ACEI/ARB, angiotensin converting enzyme inhibitor/angiotensin receptor
blocker; HVEI, high-voltage electrical injury.
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HVEI to the upper arms inevitably lead to amputation
because the massively destroyed vessel walls easily
undergo coagulation necrosis, leading to thrombosis and
local obstruction of blood flow. The distal ends of the
injured limbs may then become gangrenous [5,14].
In the animal model, a more severe injury was
induced in the vessel wall by an electric current than
would occur from a mechanical injury [9,15]. With the
mouse femoral artery electrical injury model, the
endothelial cells started to proliferate immediately after
injury and proliferated very actively during the first two
weeks. In the first week after injury, the media and
neointima both contained a heterogeneous mix of
smooth muscle cells and leukocytes, which proliferated
actively. The majority of the cells in the media and
neointima had proliferated maximally by two weeks
after injury and had become more quiescent by four
weeks [9,16,17]. In the present study, the FMD and
NMD values at six weeks were still lower than the
control group values. This means that the cellular pro-
cess is essentially complete in four weeks [9] and yet
functional abnormality persists for at least six weeks
(maybe longer). Therefore, there seems little prospect of
improvement in histological tissue repair and this may
be relevant to the longevity of the disabling symptoms
seen. This result indicates that the approaches to lessen
the damage and support the recovery of the arterial
endothelium and smooth muscle should be initiated as
rapidly as possible after an electrical injury. In our opi-
nion, anti-oxidants or nitric oxide favoring agents, such
as vitamin E, L-arginine, or trimetazidine could be con-
sidered [18,19]. If the victim has hypertension, an angio-
tensin converting enzyme inhibitor, angiotensin receptor
antagonist, or nebivolol might be a beneficial antihyper-
tensive agent to the endothelium [20].
HVEI to the upper extremities may result in amputa-
tion or graft surgery, although some patients are able to
use their arms or legs without major disability if they do




< 48 hrs (n = 25) 6 Weeks (n = 23)
Systolic blood pressure (mmHg) 120 ± 14 146 ± 14a 120 ± 8
Diastolic blood pressure (mmHg) 71 ± 13 84 ± 13a 76 ± 7
Heart rate (beats/min) 72 ± 8 83 ± 10a 74 ± 4
LVEF (%) 64 ± 4 66 ± 3 66 ± 5
Size of brachial artery (mm) 3.9 ± 0.4 4.4 ± 0.6a 4.2 ± 0.5
aP value < 0.01 versus control. HVEI, high-voltage electrical injury; LVEF, left ventricular ejection fraction.
Figure 1 Changes in FMD across the study compared with the
control group. The initial FMD was significantly lower in the HVEI
group (n = 25) than in the control group (n = 25; 2.1% ± 1.2%
versus 13.6% ± 3.4%, P < 0.01). At the six week follow-up, the FMD
was improved in the HVEI group compared with the initial FMD
(2.1% ± 1.2% versus 5.1% ± 2.1%, P < 0.01) but it was still lower
than the FMD of the control group (5.1% ± 2.1% versus 13.6% ±
3.4%, P < 0.01). *P < 0.01 versus baseline and †P < 0.01 versus
control group. FMD, flow-mediated dilation; HVEI, high-voltage
electrical injury.
Figure 2 Changes in NMD across the study compared with the
control group. The initial NMD was significantly lower in the HVEI
group (n = 25) than in the control group (n = 25; 7.3% ± 4.7%
versus 20.4% ± 4.1%, P < 0.01). At the six week follow-up, the NMD
was improved in the HVEI group compared with the initial NMD
(7.3% ± 4.7% versus 11.4% ± 6.7%, P < 0.01) but it was still lower
than the NMD of the control group (11.4% ± 6.7% versus 20.4% ±
4.1%, P < 0.01).*P < 0.01 versus baseline and †P < 0.01 versus
control group. HVEI, high-voltage electrical injury; NMD, nitrate-
mediated dilation.
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Conclusions
not have severe vascular damage or major tissue loss.
Unfortunately, however, little information exists regard-
ing the process and prognosis involved in the vascular
damage caused by HVEI in humans. The present study
showed that continuous impairment of the brachial
arterial function occurred that involved the endothelium
and smooth muscle, even if the victim did not have ser-
ious tissue damage or upper extremity loss. This finding
means that long-term cautious care is needed for all vic-
tims of HVEI, as they have an increased risk of throm-
bosis or stenosis of the artery in the injured arm. In this
study, two patients were not examined by FMD and
NMD at the six week follow-up because of musculocu-
taneous flap failure and amputation of their distal
injured arms, which might have been caused by insuffi-
cient arterial supply due to thrombosis and obstruction
of the injured artery. In patients with severe high-vol-
tage injury, Urich et al. showed that clotting activation
and hypo-fibrinolysis led to progressive tissue necrosis
and delayed arterial thrombosis [21]. In addition, a
recent study showed that the reconstruction of tissue
defects after an electrical trauma is associated with
higher complication rates because of thrombus forma-
tion in injured arteries [22].
In this study, nine patients had unilateral upper extre-
mity HVEI and three of the nine patients suffered from
severe contralateral axillar area wounds as exit-point
injuries, which may involve the axillary artery. The
injured axillary artery may affect the distal blood flow of
the distal brachial artery and influence the results of the
FMD and NMD of the contralateral uninjured arm.
Therefore, the FMD of the contralateral arm was evalu-
ated in six patients. In these patients, the six week fol-
low-up FMD was significantly improved in the HVEI arm
compared with the baseline FMD. In the contralateral
uninjured arm, there was no significant improvement in
the six week FMD compared with the baseline FMD and
the six week FMD was significantly lower than the nor-
mal control. This means that although the contralateral
arm was not directly injured by the high voltage current,
there might be systemic effects affecting areas that are
distant from the direct current passage and the impair-
ment of endothelial function may continue.
This study has several potential limitations. First,
HVEI usually causes extensive arterial injuries associated
with occlusive thrombosis, aneurysm formation and ves-
sel wall rupture. In this study, 45% of the HVEI patients
were not included due to the seriousness of their arm
injuries or systemic damage (n = 42) observed during
the screening. Therefore, there was a possibility that
only patients with less severe tissue damage and main-
tained arterial flow would be enrolled in the study. Sec-
ond, FMD may be influenced, to varying degrees, by
many factors such as sympathetic tone, medications,
and caffeine use. In addition, during the initial FMD
study after HVEI, the patients might have been in an
especially stressed condition, with increased sympathetic
tone, than at the six week follow-up FMD, which might
have decreased the initial FMD value [23]. Third, after
HVEI, the integrity of the endothelium is crucial for
physiologic vascular function. With increasing endothe-
lial dysfunction, uncontrolled clotting activation and
ischemia are initiated. This, in turn, enhances a vicious
cycle, leading to multiple organ failure and death.
Therefore, biomarkers reflecting this special compart-
ment, such as the von Willebrand factor, asymmetric
dimethyl arginine, angiopoietin 1 and 2, and the vascular
endothelial growth factor may help in the early detec-
tion of local and systemic endothelial dysfunction and
its complications after HVEI, but we did not evaluate
this issue [24]. Fourth, the last follow-up FMD and
NMD were measured six weeks after HVEI and it
remains unanswered whether different results would
have been obtained with an examination at a later fol-
low-up date.
In conclusion, after HVEI, the endothelial and smooth
muscle functions of the brachial artery were significantly
decreased for at least six weeks compared to the arterial
functions of control patients. Long-term cautious care is
needed when treating all victims of HVEI, as they might
Figure 3 Changes in FMD of the unilateral upper extremity
HVEI compared with the contralateral uninjured arm in six
patients. The six week follow-up FMD was significantly improved in
the HVEI arm compared with the initial FMD (1.8% ± 0.6% versus
4.4% ± 1.6%, P < 0.01). However, in the contralateral uninjured arm,
there was no difference between FMDs in the initial study and at
the six week follow-up (5.5% ± 1.4% versus 6.9% ± 2.2%, P = 0.26).
In addition, the six week follow-up FMD of the contralateral injured
arm was significantly lower than the matched control (6.9% ± 2.2%
versus 13.6% ± 4.4%, P < 0.01).*P < 0.01 versus baseline; FMD, flow-
mediated dilation; HVEI, high-voltage electrical injury.
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be at increased risk for thrombosis and stenosis of the
arteries of the injured arm.
Key messages
● The endothelial and smooth muscle functions of the
brachial artery were significantly decreased for at least
six weeks after a high-voltage electrical injury.
● Although the contralateral arm was not directly
injured by the high voltage current, there might be
effects on endothelial dysfunction caused by the high-
voltage electrical injury and the impairment of the
endothelial function may continue.
● Long-term cautious care is needed when treating all
victims of high-voltage electrical injury, as they might be
at increased risk of thrombosis and stenosis of the
arteries of the injured arm.
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